Literature DB >> 7502185

High-level quinolone resistance in Neisseria gonorrhoeae: a report of two cases.

J W Tapsall1, E A Limnios, C Thacker, B Donovan, S D Lynch, L J Kirby, K A Wise, C J Carmody.   

Abstract

BACKGROUND AND OBJECTIVES: Fluoroquinolones are widely used oral agents for treating Neisseria gonorrhoeae. Resistance to these agents is sporadic and usually at a low level. Two instances of high-dose ciprofloxacin regimens failing in the treatment of gonococcal infection, caused by strains with high-level quinolone resistance, are reported. STUDY
DESIGN: This is a case report.
CONCLUSION: High-level resistance to quinolone antibiotics resulting in treatment failure was observed in two distinct gonococcal isolates from patients infected in the Philippines (ciprofloxacin; minimal inhibitory contribution = 16 mg/l). Continued monitoring of the quinolone sensitivity of Neisseria gonorrhoeae is appropriate and prudent.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7502185     DOI: 10.1097/00007435-199509000-00007

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  10 in total

1.  Antimicrobial resistance of Neisseria gonorrhoeae and high prevalence of ciprofloxacin-resistant isolates in Japan, 1993 to 1998.

Authors:  M Tanaka; H Nakayama; M Haraoka; T Saika
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 2.  Antimicrobial agents and gonorrhoea: therapeutic choice, resistance and susceptibility testing.

Authors:  C A Ison
Journal:  Genitourin Med       Date:  1996-08

3.  Rapid screening of point mutations of the Neisseria gonorrhoeae parC gene associated with resistance to quinolones.

Authors:  T Deguchi; M Yasuda; M Nakano; E Kanematsu; S Ozeki; Y Nishino; T Ezaki; S Maeda; I Saito; Y Kawada
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

4.  Rapid detection of point mutations of the Neisseria gonorrhoeae gyrA gene associated with decreased susceptibilities to quinolones.

Authors:  T Deguchi; M Yasuda; M Nakano; S Ozeki; T Ezaki; S Maeda; I Saito; Y Kawada
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

5.  Antibiotic susceptibility patterns of Neisseria meningitidis isolates from patients and asymptomatic carriers.

Authors:  L Arreaza; L de La Fuente; J A Vázquez
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

6.  High prevalence of high-level ciprofloxacin resistance in Neisseria gonorrhoeae in Tel Aviv, Israel: correlation with response to therapy.

Authors:  Michael Dan; Francesca Poch; Bracha Sheinberg
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

7.  Susceptibilities of Neisseria gonorrhoeae isolates containing amino acid substitutions in GyrA, with or without substitutions in ParC, to newer fluoroquinolones and other antibiotics.

Authors:  M Tanaka; H Nakayama; M Haraoka; T Saika; I Kobayashi; S Naito
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

8.  Drift in susceptibility of Neisseria gonorrhoeae to ciprofloxacin and emergence of therapeutic failure.

Authors:  C A Ison; P J Woodford; H Madders; E Claydon
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

Review 9.  Antimicrobial resistance in Neisseria gonorrhoeae: history, molecular mechanisms and epidemiological aspects of an emerging global threat.

Authors:  Ana Paula Ramalho da Costa-Lourenço; Késia Thaís Barros Dos Santos; Beatriz Meurer Moreira; Sergio Eduardo Longo Fracalanzza; Raquel Regina Bonelli
Journal:  Braz J Microbiol       Date:  2017-07-12       Impact factor: 2.476

10.  Epitope determination of immunogenic proteins of Neisseria gonorrhoeae.

Authors:  Daniel O Connor; Lena Danckert; Sebastian Hoppe; Frank F Bier; Markus von Nickisch-Rosenegk
Journal:  PLoS One       Date:  2017-07-19       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.